-
1
-
-
27744467604
-
Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: A cardiovascular perspective
-
Dumasia, R.; Eagle, K. A.; Kline-Rogers, E.; May, N.; Cho, L.; Mukherjee, D. Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5, 377-386.
-
(2005)
Curr. Drug Targets Cardiovasc. Haematol. Disord
, vol.5
, pp. 377-386
-
-
Dumasia, R.1
Eagle, K.A.2
Kline-Rogers, E.3
May, N.4
Cho, L.5
Mukherjee, D.6
-
2
-
-
23644456172
-
Therapeutic roles of peroxisome proliferator-activated receptor agonists
-
Staels, B.; Fruchart, J. C. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005, 54, 2460-2470.
-
(2005)
Diabetes
, vol.54
, pp. 2460-2470
-
-
Staels, B.1
Fruchart, J.C.2
-
3
-
-
32844469572
-
Effects of Rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
-
Chu, C. S.; Lee, K. T.; Lee, M. Y.; Su, H. M.; Voon, W. C.; Sheu, S. H.; Lai, W. T. Effects of Rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Am. J. Cardiol. 2006, 97, 646-650.
-
(2006)
Am. J. Cardiol
, vol.97
, pp. 646-650
-
-
Chu, C.S.1
Lee, K.T.2
Lee, M.Y.3
Su, H.M.4
Voon, W.C.5
Sheu, S.H.6
Lai, W.T.7
-
4
-
-
0343683281
-
Mechanisms of action of troglitazone in prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells
-
Yasunari, K.; Kohono, M.; Kano, H.; Yokokawa, M.; Yoshikawa, J. Mechanisms of action of troglitazone in prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ. Res. 1997, 81, 953-962.
-
(1997)
Circ. Res
, vol.81
, pp. 953-962
-
-
Yasunari, K.1
Kohono, M.2
Kano, H.3
Yokokawa, M.4
Yoshikawa, J.5
-
5
-
-
0031685956
-
Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanisms
-
Ishizuka, T.; Itaya, S.; Wada, H.; Ishizawa, M.; Kimura, M.; Kajita Kanoh, Y.; Mjura, A.; Muto, N.; Yasuda, K. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanisms. Diabetes 1998, 47, 1494-1500.
-
(1998)
Diabetes
, vol.47
, pp. 1494-1500
-
-
Ishizuka, T.1
Itaya, S.2
Wada, H.3
Ishizawa, M.4
Kimura, M.5
Kajita Kanoh, Y.6
Mjura, A.7
Muto, N.8
Yasuda, K.9
-
6
-
-
0031822381
-
Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells
-
Kihara, S.; Ouchi, N.; Funahaschi, T.; Shinohara, E.; Tamura, R.; Yamashita, S.; Matsuzawa, Y. Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. Atherosclerosis 1998, 136, 163-168.
-
(1998)
Atherosclerosis
, vol.136
, pp. 163-168
-
-
Kihara, S.1
Ouchi, N.2
Funahaschi, T.3
Shinohara, E.4
Tamura, R.5
Yamashita, S.6
Matsuzawa, Y.7
-
7
-
-
0031034711
-
Trogliatzone inhibits angiotensin II induced DNA synthesis and migration in vascular smooth muscle cells
-
Graf, K.; Xi, X. P.; Hsueh, W. A.; Law, R. E. Trogliatzone inhibits angiotensin II induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Lett. 1997, 400, 119-121.
-
(1997)
FEBS Lett
, vol.400
, pp. 119-121
-
-
Graf, K.1
Xi, X.P.2
Hsueh, W.A.3
Law, R.E.4
-
8
-
-
2142710075
-
Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents
-
Dandona, P.; Aljada, A. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. J. Diabetes Complications 2004, 18, 91-102.
-
(2004)
J. Diabetes Complications
, vol.18
, pp. 91-102
-
-
Dandona, P.1
Aljada, A.2
-
9
-
-
0942276496
-
PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with tipe 2 diabetes
-
Bagi, Z.; Koller, A.; Kaley, G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with tipe 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H742-H748.
-
(2004)
Am. J. Physiol. Heart Circ. Physiol
, vol.286
-
-
Bagi, Z.1
Koller, A.2
Kaley, G.3
-
10
-
-
73649096435
-
Role of oxidative stress in diabetic complications
-
Baynes, J. W.; Thorpe, S. R. Role of oxidative stress in diabetic complications. Lancet 1996, 347, 444-445.
-
(1996)
Lancet
, vol.347
, pp. 444-445
-
-
Baynes, J.W.1
Thorpe, S.R.2
-
11
-
-
0027318772
-
Hyperglycemic pseudohypoxia and diabetic complications
-
Williamson, J. R.; Chang, K.; Fragos, M.; Hasan, K. S.; Ido, Y.; Kawamura, T.; Nyengaard, J. R.; van den Enden, M.; Kilo, C.; Tilton, R. G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993, 42, 801-813.
-
(1993)
Diabetes
, vol.42
, pp. 801-813
-
-
Williamson, J.R.1
Chang, K.2
Fragos, M.3
Hasan, K.S.4
Ido, Y.5
Kawamura, T.6
Nyengaard, J.R.7
van den Enden, M.8
Kilo, C.9
Tilton, R.G.10
-
12
-
-
0034643340
-
Normalizing mithocondrial superoxide production blocks three pathways of hyperglycaemic damage
-
Nashikawa, T.; Eldestein, D.; Du, X. L.; Yamagishi, S.; Matsumura, T.; Kaneda, Y.; Yorek, M. A.; Beebe, D.; Oates, P. J.; Hammes, H. P.; Giardino, I.; Brownlee, M. Normalizing mithocondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404, 787-790.
-
(2000)
Nature
, vol.404
, pp. 787-790
-
-
Nashikawa, T.1
Eldestein, D.2
Du, X.L.3
Yamagishi, S.4
Matsumura, T.5
Kaneda, Y.6
Yorek, M.A.7
Beebe, D.8
Oates, P.J.9
Hammes, H.P.10
Giardino, I.11
Brownlee, M.12
-
13
-
-
21344466513
-
Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients
-
Pistrosch, F.; Herbrig, K.; Kindel, B.; Passauer, J.; Fischer, S.; Gross, P. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005, 54, 2206-2211.
-
(2005)
Diabetes
, vol.54
, pp. 2206-2211
-
-
Pistrosch, F.1
Herbrig, K.2
Kindel, B.3
Passauer, J.4
Fischer, S.5
Gross, P.6
-
14
-
-
3042811373
-
Peroxisome proliferator-activated receptor-gamma agonist Rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease
-
Sidhu, J. S.; Cowan, D.; Tooze, J. A.; Kaski, J. C. Peroxisome proliferator-activated receptor-gamma agonist Rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease. Am. Heart J. 2004, 147, 25.
-
(2004)
Am. Heart J
, vol.147
, pp. 25
-
-
Sidhu, J.S.1
Cowan, D.2
Tooze, J.A.3
Kaski, J.C.4
-
15
-
-
0035433149
-
Platelet dysfunction in type 2 diabetes
-
Vinik, A. I.; Erbas, T.; Park, T. S.; Nolan, R.; Pittenger, G. L. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001, 24, 1476-1485.
-
(2001)
Diabetes Care
, vol.24
, pp. 1476-1485
-
-
Vinik, A.I.1
Erbas, T.2
Park, T.S.3
Nolan, R.4
Pittenger, G.L.5
-
16
-
-
36348948505
-
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism
-
Ceolotto, G.; Gallo, A.; Papparella, I.; Franco, L.; Murphy, E.; Iori, E.; Pagnin, E.; Fadini, G. P.; Albiero, M.; Semplicini, A.; Avogaro, A. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler., Thromb., Vasc. Biol. 2007, 12, 2627-2633.
-
(2007)
Arterioscler., Thromb., Vasc. Biol
, vol.12
, pp. 2627-2633
-
-
Ceolotto, G.1
Gallo, A.2
Papparella, I.3
Franco, L.4
Murphy, E.5
Iori, E.6
Pagnin, E.7
Fadini, G.P.8
Albiero, M.9
Semplicini, A.10
Avogaro, A.11
-
17
-
-
57649129429
-
Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: A meta-analysis of randomized, controlled trials
-
Nagajothi, N.; Adigopula, S.; Balamuthusamy, S.; Velazquez-Cecena, J. L.; Raghunathan, K.; Khraisat, A.; Singh, S.; Molnar, J.; Khosla, S.; Benatar, D. Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials. Am. J. Ther. 2008, 15, 506-511.
-
(2008)
Am. J. Ther
, vol.15
, pp. 506-511
-
-
Nagajothi, N.1
Adigopula, S.2
Balamuthusamy, S.3
Velazquez-Cecena, J.L.4
Raghunathan, K.5
Khraisat, A.6
Singh, S.7
Molnar, J.8
Khosla, S.9
Benatar, D.10
-
18
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen, S. E.; Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 2007, 356, 2457-2471.
-
(2007)
N. Engl. J. Med
, vol.356
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
19
-
-
34548580881
-
Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis
-
Singh, S.; Loke, Y. K.; Furberg, C. D. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA, J. Am. Med. Assoc. 2007, 298, 1189-1195.
-
(2007)
JAMA, J. Am. Med. Assoc
, vol.298
, pp. 1189-1195
-
-
Singh, S.1
Loke, Y.K.2
Furberg, C.D.3
-
20
-
-
58849094131
-
Long-term use of thiazolidinediones and fractures in type 2 diabetes: A meta-analysis
-
Loke, Y. K.; Singh, S.; Furberg, C. D. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. Can. Med. Assoc. J. 2009, 180, 16-17.
-
(2009)
Can. Med. Assoc. J
, vol.180
, pp. 16-17
-
-
Loke, Y.K.1
Singh, S.2
Furberg, C.D.3
-
21
-
-
0034772403
-
The role of separation science in proteomics research
-
Issaq, H. J. The role of separation science in proteomics research. Electrophoresis 2001, 22, 3629-3638.
-
(2001)
Electrophoresis
, vol.22
, pp. 3629-3638
-
-
Issaq, H.J.1
-
22
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
-
(1976)
Anal. Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
23
-
-
33748755546
-
Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects
-
Puricelli, L.; Iori, E.; Millioni, R.; Arrigoni, G.; James, P.; Vedovato, M.; Tessari, P. Proteome analysis of cultured fibroblasts from type 1 diabetic patients and normal subjects. J. Clin. Endocrinol. Metab. 2006, 91, 3507-3514.
-
(2006)
J. Clin. Endocrinol. Metab
, vol.91
, pp. 3507-3514
-
-
Puricelli, L.1
Iori, E.2
Millioni, R.3
Arrigoni, G.4
James, P.5
Vedovato, M.6
Tessari, P.7
-
24
-
-
0036211240
-
Primary skin fibroblasts as human model system for proteome analysis
-
Lehr, S.; Kotzka, J.; Knebel, B.; Schiller, M.; Krone, W.; Muller-Wieland, D. Primary skin fibroblasts as human model system for proteome analysis. Proteomics 2002, 2 (3), 280-7.
-
(2002)
Proteomics
, vol.2
, Issue.3
, pp. 280-287
-
-
Lehr, S.1
Kotzka, J.2
Knebel, B.3
Schiller, M.4
Krone, W.5
Muller-Wieland, D.6
-
25
-
-
0032774579
-
Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis
-
Huck, S.; Deveaud, E.; Namane, A.; Zouali, M. Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis. FASEB J. 1999, 13, 1415-1422.
-
(1999)
FASEB J
, vol.13
, pp. 1415-1422
-
-
Huck, S.1
Deveaud, E.2
Namane, A.3
Zouali, M.4
-
26
-
-
2442421194
-
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
-
Ceriello, A.; Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler., Thromb., Vasc. Biol. 2004, 24, 816-823.
-
(2004)
Arterioscler., Thromb., Vasc. Biol
, vol.24
, pp. 816-823
-
-
Ceriello, A.1
Motz, E.2
-
27
-
-
15944412463
-
Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism
-
Gallo, A.; Ceolotto, G.; Pinton, P.; Iori, E.; Murphy, E.; Rutter, G. A.; Rizzuto, R.; Semplicini, A.; Avogaro, A. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes 2005, 54, 1123-1131.
-
(2005)
Diabetes
, vol.54
, pp. 1123-1131
-
-
Gallo, A.1
Ceolotto, G.2
Pinton, P.3
Iori, E.4
Murphy, E.5
Rutter, G.A.6
Rizzuto, R.7
Semplicini, A.8
Avogaro, A.9
-
28
-
-
39149125115
-
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells
-
Iori, E.; Pagnin, E.; Gallo, A.; Calò, L.; Murphy, E.; Ostuni, F.; Fadini, G. P.; Avogaro, A. Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells. Life Sci. 2008, 82, 383-392.
-
(2008)
Life Sci
, vol.82
, pp. 383-392
-
-
Iori, E.1
Pagnin, E.2
Gallo, A.3
Calò, L.4
Murphy, E.5
Ostuni, F.6
Fadini, G.P.7
Avogaro, A.8
-
29
-
-
0034843965
-
Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis
-
Choy, J. C.; Granville, D. J.; Hunt, D. W.; McManus, B. M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell. Cardiol. 2001, 33, 1673-1690.
-
(2001)
J. Mol. Cell. Cardiol
, vol.33
, pp. 1673-1690
-
-
Choy, J.C.1
Granville, D.J.2
Hunt, D.W.3
McManus, B.M.4
-
30
-
-
29244476043
-
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity
-
Jung, T. W.; Lee, J. Y.; Shim, W. S.; Kang, E. S.; Kim, S. K.; Ahn, C. W.; Lee, H. C.; Cha, B. S. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Biochem. Biophys. Res. Commun. 2006, 340, 221-227.
-
(2006)
Biochem. Biophys. Res. Commun
, vol.340
, pp. 221-227
-
-
Jung, T.W.1
Lee, J.Y.2
Shim, W.S.3
Kang, E.S.4
Kim, S.K.5
Ahn, C.W.6
Lee, H.C.7
Cha, B.S.8
-
31
-
-
47949108186
-
Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis
-
Han, S. J.; Kang, E. S.; Hur, K. Y.; Kim, H. J.; Kim, S. H.; Yun, C. O.; Choi, S. E.; Ahn, C. W.; Cha, B. S.; Kang, Y.; Lee, H. C. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis. Horm. Res. 2008, 70, 165-173.
-
(2008)
Horm. Res
, vol.70
, pp. 165-173
-
-
Han, S.J.1
Kang, E.S.2
Hur, K.Y.3
Kim, H.J.4
Kim, S.H.5
Yun, C.O.6
Choi, S.E.7
Ahn, C.W.8
Cha, B.S.9
Kang, Y.10
Lee, H.C.11
-
32
-
-
4043145689
-
Protein glycation: A firm link to endothelial cell dysfunction
-
Wautier, J. L.; Schmidt, A. M. Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 2004, 95, 233-238.
-
(2004)
Circ. Res
, vol.95
, pp. 233-238
-
-
Wautier, J.L.1
Schmidt, A.M.2
-
33
-
-
0038359684
-
-
Mart?́n-Gallán, P.; Carrascosa, A.; Gussinyé, M.; Dom?́nguez, C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radical Biol. Med. 2003, 34, 1563-1574.
-
Mart?́n-Gallán, P.; Carrascosa, A.; Gussinyé, M.; Dom?́nguez, C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radical Biol. Med. 2003, 34, 1563-1574.
-
-
-
-
34
-
-
0028834378
-
The dark side of glucose
-
Schmidt, A. M.; Yan, S. D.; Stern, D. M. The dark side of glucose. Nat. Med. 1995, 1, 1002-1004.
-
(1995)
Nat. Med
, vol.1
, pp. 1002-1004
-
-
Schmidt, A.M.1
Yan, S.D.2
Stern, D.M.3
-
35
-
-
65549166721
-
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins
-
Wu, J. S.; Lin, T. N.; Wu, K. K. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J. Cell Physiol. 2009a, 220, 58-71.
-
(2009)
J. Cell Physiol
, vol.220
, pp. 58-71
-
-
Wu, J.S.1
Lin, T.N.2
Wu, K.K.3
-
36
-
-
62649096776
-
Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation
-
Wu, J. S.; Cheung, W. M.; Tsai, Y. S.; Chen, Y. T.; Fong, W. H.; Tsai, H. D.; Chen, Y. C.; Liou, J. Y.; Shyue, S. K.; Chen, J. J.; Chen, Y. E.; Maeda, N.; Wu, K. K.; Lin, T. N. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 2009b, 119, 1124-1134.
-
(2009)
Circulation
, vol.119
, pp. 1124-1134
-
-
Wu, J.S.1
Cheung, W.M.2
Tsai, Y.S.3
Chen, Y.T.4
Fong, W.H.5
Tsai, H.D.6
Chen, Y.C.7
Liou, J.Y.8
Shyue, S.K.9
Chen, J.J.10
Chen, Y.E.11
Maeda, N.12
Wu, K.K.13
Lin, T.N.14
-
37
-
-
20544441001
-
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: Involvement of Akt and intracellular calcium
-
Singh, N.; Webb, R.; Adams, R.; Evans, S. A.; Al-Mosawi, A.; Evans, M.; Roberts, A. W.; Thomas, A. W. The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. Biochem. Biophys. Res. Commun. 2005, 333, 455-462.
-
(2005)
Biochem. Biophys. Res. Commun
, vol.333
, pp. 455-462
-
-
Singh, N.1
Webb, R.2
Adams, R.3
Evans, S.A.4
Al-Mosawi, A.5
Evans, M.6
Roberts, A.W.7
Thomas, A.W.8
|